@article{JTD23985,
author = {Anders Mellemgaard},
title = {Broader indications for checkpoint inhibitors in NSCLC},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {9},
year = {2018},
keywords = {},
abstract = {It has been 23 years since the results from a meta-analysis of several randomized trials comparing first line chemotherapy with best supportive care for metastatic non-small cell lung cancer (NSCLC) was published (1).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/23985}
}